Media Release Osteoporosis Canada and the International Osteoporosis Foundation underline their shared goal of improving clinical outcomes and preventing recurrent fractures in patients who have sustained fractures due to osteoporosis. […]

A recently released Canadian research study confirms what has been shown in past preliminary studies; – inflammation of the eye as a possible side effect of bisphosphonate therapy is very […]

Chill time: 4 hours Chill time: 4 hours Ingredients   Preparation In Partnership With Ingredients Preparation In Partnership With RECIPE TIP DID YOU KNOW? Bone is a living tissue, that […]

Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

Tools Algorithm 1 Integrated approach to the management of bone health and fracture prevention in postmenopausal females and males 50 years and older. DOWNLOAD Algorithm 2 Approach to pharmacotherapy to […]

Accessibility Accessibility Accessibility for Ontarians With Disabilities Act (AODA) Accessibility for Ontarians With Disabilities Act (AODA) Osteoporosis Canada is committed to excellence in servicing all customers including people with disabilities. […]

Ingredients   Preparation In Partnership With Ingredients Preparation In Partnership With RECIPE TIP DID YOU KNOW? Bone is a living tissue, that is constantly renewing and repairing itself from everyday […]

Dr. Adrian Lau, Dr. Rowena Ridout, Dr. Claudia Gagnon, Dr. Zahra Bardai, and Dr. Emma Billington. Recommendations from Osteoporosis Canada Rapid Response Team. The Canadian Centre on Substance Use and […]